Basic Information
BioMarin Pharmaceutical is a biopharmaceutical company that develops enzyme-based therapies for chronic genetic diseases. The company has three highly promising orphan drugs in its pipeline, one of which is the gene therapy for hemophilia A, valoctocogene roxaparvovec (BMN 270).
BioMarin Pharmaceutical Inc.
California,United States of America
more than 500 people
January 01, 2003
info@bmrn.nl
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios